Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM) Article

Krauze, Andra V, Won, Minhee, Graves, Christian et al. (2013). Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM) . Biomarker Research, 1 10.1186/2050-7771-1-29

cited authors

  • Krauze, Andra V; Won, Minhee; Graves, Christian; Corn, Ben W; Muanza, Thierry M; Howard, Steven P; Mahadevan, Arul; Schultz, Christopher J; Haas, Michael L; Mehta, Minesh P; Camphausen, Kevin A

authors

publication date

  • January 1, 2013

published in

keywords

  • ANGIOGENESIS
  • BLOOD
  • GLIOMAS
  • GROWTH-FACTOR VEGF
  • Glioblastoma Multiforme (GBM)
  • Life Sciences & Biomedicine
  • Medicine, Research & Experimental
  • Oncology
  • PHASE-II
  • PROGNOSIS
  • PROGRESSION
  • RADIOTHERAPY
  • REPAIR GENE MGMT
  • Radiation therapy
  • Research & Experimental Medicine
  • Science & Technology
  • TEMOZOLOMIDE
  • Tumor recurrence
  • Urinary biomarker
  • VEGF (vascular endothelial factor)

Digital Object Identifier (DOI)

volume

  • 1